| 2026-08-06 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| Transcript | Earnings call transcript |
| 2026-08-05 | Press release | GRAIL Reports Second Quarter 2026 Financial Results |
| 2026-08-05 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-05 | Transcript | Q2 FY26 earnings call transcript |
| 2026-07-30 | Press release | GRAIL to Present at the Canaccord Genuity 46th Annual Growth Conference |
| 2026-07-29 | Press release | GRAIL to Announce Second Quarter 2026 Financial Results |
| 2026-07-16 | Press release | Priority Health Collaborates With GRAIL as the First Michigan Health Plan to Offer the Galleri® Multi-Canc |
| 2026-06-25 | Press release | GRAIL Completes $110 Million Equity Financing With Samsung Entities View Press Release |
| 2026-06-22 | 8-K | Form 8-K, Item 5.07 |
| 2026-06-01 | 8-K | Form 8-K, Item 5.02 |
| 2026-05-31 | Deck | GRAIL 2026 ASCO Analyst Call |
| 2026-05-31 | Press release | GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantiall |
| 2026-05-30 | Press release | GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Di |
| 2026-05-27 | Press release | GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
| 2026-05-26 | Press release | GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference View Press Release |
| 2026-05-21 | Press release | GRAIL to Present at the 2026 Jefferies Global Healthcare Conference View Press Release |
| 2026-05-07 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-05-05 | Press release | GRAIL Reports First Quarter 2026 Financial Results |
| 2026-05-05 | 8-K | Form 8-K, Item 2.02 results |
| 2026-04-30 | Press release | GRAIL to Present at the BofA Securities 2026 Health Care Conference View Press Release |
| 2026-04-28 | Proxy | Definitive proxy statement |
| 2026-04-21 | Press release | GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting View Press Releas |
| 2026-04-07 | Press release | GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Acc |
| 2026-03-12 | Press release | GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor View P |
| 2026-03-12 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-24 | Press release | GRAIL to Present at the TD Cowen 46th Annual Health Care Conference |
| 2026-02-21 | Transcript | Q4 FY25 earnings call transcript |
| 2026-02-19 | Press release | GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results |
| 2026-02-19 | Press release | Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate - GRAIL, Inc · Q1 2026 |
| 2026-02-19 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-16 | Press release | GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results View Press Release |
| 2026-01-29 | Press release | GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test Vie |
| 2026-01-12 | Deck | 44th Annual J.P. Morgan Healthcare Conference · 2025 |
| 2026-01-12 | 8-K | Form 8-K, Item 2.02 results |
| 2025-12-15 | Press release | GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference View Press Release |
| 2025-11-18 | Press release | GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference View Press Release |
| 2025-11-14 | 8-K | Form 8-K, Item 8.01 |
| 2025-11-13 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-11-12 | Press release | GRAIL Reports Third Quarter 2025 Financial Results |